{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:53:45Z","timestamp":1789692825738,"version":"4.0.1"},"reference-count":37,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Gastroenterol"],"accepted":{"date-parts":[[2019,7,16]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To describe probiotics including a <jats:italic>Lactobacillus gasseri<\/jats:italic> strain LG21 used for the upper gastrointestinal tract, which are considered to act through improvement of indigenous microbiota inhabiting there.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Background and design<\/jats:title>\n                  <jats:p>Because the early definition of probiotics emphasized their effects on improving the intestinal microbial ecology, their effects on the intestinal tract and its immunity have been considered common general benefits associated with probiotics. This conclusion was also based on a body of successful clinical trials whose endpoints were the prevention or treatment of intestinal diseases. In contrast to intestinal microbiota, our understanding of the role of gastric microbiota in human health and physiology remains poor, as the bacterial load in the stomach is considered too small to exert a significant effect due to the highly acidic environment of the human stomach. Therefore, the intervention using probiotics in the stomach is still limited at present.Results:In this article using representative 38 quoted articles, we first describe the gastric microbiota, as the indigenous microbiota in the stomach is thought to be significantly involved in the pathophysiology of this organ, since probiotics exert their beneficial effects through improving the resident microbiota. We then review the present status and future prospects of probiotics for the treatment of upper gastrointestinal diseases by quoting representative published articles, including our basic and clinical data.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Probiotics have been demonstrated to suppress Helicobacter pylori in the stomach, and are also expected to improve functional dyspepsia through the correction of dysbiotic gastric microbiota.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgast-2019-000314","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T07:05:19Z","timestamp":1565679919000},"page":"e000314","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Probiotic <i>L. gasseri<\/i> strain (LG21) for the upper gastrointestinal tract acting through improvement of indigenous microbiota"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4175-8315","authenticated-orcid":false,"given":"Yasuhiro","family":"Koga","sequence":"first","affiliation":[{"name":"Gastroenterology, Tokai University School of Medicine, Isehara City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Ohtsu","sequence":"additional","affiliation":[{"name":"Food Microbiology Research Laboratories, Meiji, Hachiouji City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Kimura","sequence":"additional","affiliation":[{"name":"Food Microbiology Research Laboratories, Meiji, Hachiouji City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Asami","sequence":"additional","affiliation":[{"name":"Food Microbiology Research Laboratories, Meiji, Hachiouji City, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,8,12]]},"reference":[{"key":"2025073013415874000_6.1.e000314.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.1989.tb05105.x"},{"key":"2025073013415874000_6.1.e000314.2","unstructured":"World Health Organization . Fao of the United nations and who: health and nutritional properties of probiotics in food including powdered milk with live lactic acid bacteria. 2001."},{"key":"2025073013415874000_6.1.e000314.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2014.66"},{"key":"2025073013415874000_6.1.e000314.4","doi-asserted-by":"publisher","DOI":"10.1038\/nature08821"},{"key":"2025073013415874000_6.1.e000314.5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 consensus report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"2025073013415874000_6.1.e000314.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00248-013-0192-5"},{"key":"2025073013415874000_6.1.e000314.7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506655103"},{"key":"2025073013415874000_6.1.e000314.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007985","article-title":"Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use","volume":"4","author":"Li","year":"2009","journal-title":"PLoS One"},{"key":"2025073013415874000_6.1.e000314.9","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.20","article-title":"Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract","volume":"6","author":"Tsuda","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"2025073013415874000_6.1.e000314.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020542"},{"key":"2025073013415874000_6.1.e000314.11","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12145"},{"key":"2025073013415874000_6.1.e000314.12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00365528509093749","article-title":"Bacterial overgrowth as a consequence of reduced gastric acidity","volume":"20","author":"Stockbruegger","year":"1985","journal-title":"Scand J Gastroenterol"},{"key":"2025073013415874000_6.1.e000314.13","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(80)92826-3","article-title":"Effect of cimetidine on the gastric bacterial flora","volume":"1","author":"Ruddell","year":"1980","journal-title":"Lancet"},{"key":"2025073013415874000_6.1.e000314.14","first-page":"885","article-title":"Bactericidal factors in gastric juice","volume":"4","author":"Wilder-Smith","year":"1992","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025073013415874000_6.1.e000314.15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.49"},{"key":"2025073013415874000_6.1.e000314.16","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.05230-11"},{"key":"2025073013415874000_6.1.e000314.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.021"},{"key":"2025073013415874000_6.1.e000314.18","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8612991"},{"key":"2025073013415874000_6.1.e000314.19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.gastro.2010.08.044","article-title":"Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice","volume":"140","author":"Saito","year":"2011","journal-title":"Gastroenterology"},{"key":"2025073013415874000_6.1.e000314.20","first-page":"17","article-title":"Investigation of acid-resistance mechanisms of an anti-H. pylori strain of Lactobacillus gasseri using a DNA microarray technique","volume":"62","author":"Sasaki","year":"2004","journal-title":"Bioscience and Industry"},{"key":"2025073013415874000_6.1.e000314.21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.5.709"},{"key":"2025073013415874000_6.1.e000314.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02868.x"},{"key":"2025073013415874000_6.1.e000314.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2009.00675.x"},{"key":"2025073013415874000_6.1.e000314.24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta-Analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"2025073013415874000_6.1.e000314.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06985.x"},{"key":"2025073013415874000_6.1.e000314.26","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314205"},{"key":"2025073013415874000_6.1.e000314.27","first-page":"31","article-title":"Upper gastrointestinal tract disease and probiotics","volume":"5","author":"Lambert","year":"1996","journal-title":"Asia Pacific J Clin Nutr"},{"key":"2025073013415874000_6.1.e000314.28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.81","article-title":"Functional dyspepsia","volume":"3","author":"Enck","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2025073013415874000_6.1.e000314.29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.030"},{"key":"2025073013415874000_6.1.e000314.30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00706.x"},{"key":"2025073013415874000_6.1.e000314.31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apt.13945","article-title":"Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia","volume":"45","author":"Tan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2025073013415874000_6.1.e000314.32","doi-asserted-by":"crossref","unstructured":"Takagi A , Yanagi H , Ozawa H , et al . Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-associated dyspepsia: a multicenter randomized double-blind controlled trial. Gastoenterol Res Practice 2016.","DOI":"10.1155\/2016\/7490452"},{"key":"2025073013415874000_6.1.e000314.33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000479000","article-title":"The ameliorating effect of Lactobacillus gasseri OLL2716 on functional dyspepsia in Helicobacter pylori-uninfected individuals: a randomized controlled study","volume":"96","author":"Ohtsu","year":"2017","journal-title":"Digestion"},{"key":"2025073013415874000_6.1.e000314.34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2982.2009.01449.x","article-title":"Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage","volume":"22","author":"Matsueda","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"2025073013415874000_6.1.e000314.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2017-000144","article-title":"Alteration in the gastric microbiota and its restoration by probiotics in patients with functional dyspepsia","volume":"3","author":"Igarashi","year":"2017","journal-title":"BMJ Open Gastroenterol"},{"key":"2025073013415874000_6.1.e000314.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.05.015"},{"key":"2025073013415874000_6.1.e000314.37","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303857"}],"container-title":["BMJ Open Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgast-2019-000314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:42:05Z","timestamp":1753908125000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopengastro.bmj.com\/lookup\/doi\/10.1136\/bmjgast-2019-000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,8,12]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/bmjgast-2019-000314"],"URL":"https:\/\/doi.org\/10.1136\/bmjgast-2019-000314","relation":{},"ISSN":["2054-4774"],"issn-type":[{"value":"2054-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}